Pharmafile Logo
Pharmafocus logo
Advanced Search

small-cell lung cancer

Showing 1 posts of 1 posts found.

abbvie_0

AbbVie shuts down Rova-T development in first-line advanced small-cell lung cancer following another trial failure

August 30, 2019
Medical Communications, Research and Development AbbVie, pharma, rova-t, small-cell lung cancer

AbbVie has announced its intention to terminate development of Rova-T (rovalpituzumab tesirine) in the first-line maintenance of advanced small-cell lung …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025